Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
Spotlight Innovation Inc. (0001388486)
Standardized SEC financial data for Spotlight Innovation Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001388486 · Pharmaceutical Preparations.
Return on equity
417.3%
Free cash flow
-$3.6M
Debt / equity
-0.80×
Current ratio
0.10×
Ratios for fiscal year 2017, standardized from SEC filings.
Income statement
USD
FY2016
FY2017
Revenue
—
$2K
Cost of revenue
—
$127K
Gross profit
—
-$124K
R&D expense
$233K
$742K
SG&A expense
$6.4M
$3.8M
Operating income
-$6.7M
-$4.6M
EBITDA
-$6.7M
-$4.6M
Interest expense
$9.2M
Standardized from Spotlight Innovation Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.